J Kumar Infraprojects Q4 profit slips 4% on lower revenue; declares dividend

Sanghvi Movers Q4 profit jumps 28% as demand for cranes and wind projects stays strong

Sanghvi Movers Ltdreported a 27.8% year-on-year rise in consolidated net profit for the fourth quarter ended March 2026 at ₹68.8 crore, compared with ₹53.8 crore in the corresponding quarter last year. As per the exchange filing, revenue from operations during the quarter increased 27.7% to ₹351.4 crore against ₹267.4 crore a year ago, supported by…

Read More
SpaceX IPO Filing: Musk ownership, big losses and Starlink revenue among key takeaways

SpaceX IPO Filing: Musk ownership, big losses and Starlink revenue among key takeaways

Elon Musk’s SpaceX has officially filed its IPO papers with the Securities and Exchange Commission (SEC), setting itself up for a potential debut on the Nasdaq as early as next month. The prospectus highlights significant losses, high ownership control for the world’s richest individual, and revenue dependence on one of Musk’s own companies. As per…

Read More
Jubilant Foodworks reports muted like-for-like growth in Q4; stock in focus

Jubilant Foodworks Q4 bottomline falls to 5 quarter low, topline growth slowest in 2 years

JubilantFoodWorks reported a mixed March quarter performance on Wednesday, May 20, with profit declining year-on-year and revenue growth slowing to a two-year low, while both revenue and profit missed Street expectations. The quarter also marked the company’s first decline in quarterly profit in five quarters. Standalone net profit for Q4FY26 fell 14% year-on-year to ₹42.5…

Read More
Glenmark-backed biotech firm unveils new cancer drug candidate for solid tumours

Glenmark-backed biotech firm unveils new cancer drug candidate for solid tumours

Ichnos Glenmark Innovation, Inc. (IGI), a global clinical-stage biotechnology company focused on developing multispecific antibodies in oncology, has announced a new development candidate, ISB 2301, for the potential treatment of multiple solid tumour indications. According to a press release filed with the NSE, the company said ISB 2301 is a first-in-class multispecific immune cell activator…

Read More
Mounjaro loses share in March as Semaglutide generics gain ground

Whirlpool India’s Q4 profit falls 33% despite higher sales as margins shrink; announces ₹5 dividend

Whirlpool of India Limited reported a 32.7% year-on-year decline in net profit for the fourth quarter of FY26 at ₹80.2 crore, compared with ₹119.2 crore in the corresponding quarter last year. However revenue from operations rose 8.8% year-on-year to ₹2,180.8 crore against ₹2,004.7 crore in the year-ago period. EBITDA declined 33.8% to ₹121.3 crore from…

Read More